We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
+$11.2M
Cap. Flow
+$1.58M
Cap. Flow %
0.64%
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$7.05M
2
AMZN icon
Amazon
AMZN
+$3.89M
3
QURE icon
uniQure
QURE
+$2.86M
4
BNTX icon
BioNTech
BNTX
+$2.81M
5
DXCM icon
DexCom
DXCM
+$2.78M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.6M
2
PG icon
Procter & Gamble
PG
+$3.27M
3
NVO
Novo Nordisk
NVO
+$3.16M
4
CVS icon
CVS Health
CVS
+$3.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.85M

Sector Composition

Rank Sector Weight
1 Technology 35.23%
2 Healthcare 25.2%
3 Consumer Discretionary 20.47%
4 Communication Services 8.05%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRON
426
DELISTED
Kronos Bio
KRON
-532
Closed -$2K
KRRO icon
427
Korro Bio
KRRO
$197M
-7
Closed -$1K
CYPH
428
Cypherpunk Technologies Inc
CYPH
$70M
-93
Closed -$1K
LRMR icon
429
Larimar Therapeutics
LRMR
$454M
-165
Closed -$1K
MBIO icon
430
Mustang Bio
MBIO
$4.59M
-1
Closed
MREO
431
Mereo BioPharma
MREO
$48.3M
-1,095
Closed -$1K
NAT icon
432
Nordic American Tanker
NAT
$1.36B
-261,515
Closed -$711K
NGNE icon
433
Neurogene
NGNE
$738M
-20
Closed
NRXP icon
434
NRX Pharmaceuticals
NRXP
$144M
-63
Closed
NXTC icon
435
NextCure
NXTC
$37.4M
-22
Closed -$1K
IMDX
436
Insight Molecular Diagnostics
IMDX
$147M
-56
Closed -$1K
OLMA icon
437
Olema Pharmaceuticals
OLMA
$913M
-378
Closed -$1K
ORIC icon
438
Oric Pharmaceuticals
ORIC
$1.43B
-370
Closed -$1K
OVID icon
439
Ovid Therapeutics
OVID
$489M
-660
Closed -$1K
PASG icon
440
Passage Bio
PASG
$14.8M
-26
Closed -$1K
PBYI icon
441
Puma Biotechnology
PBYI
$459M
-426
Closed -$1K
PHYS icon
442
Sprott Physical Gold
PHYS
$16B
-180,000
Closed -$2.3M
PRAX icon
443
Praxis Precision Medicines
PRAX
$10.8B
-28
Closed -$1K
PRQR icon
444
ProQR Therapeutics
PRQR
$262M
-701
Closed -$1K
PSNL icon
445
Personalis
PSNL
$1.52B
-430
Closed -$1K
QNCX icon
446
Quince Therapeutics
QNCX
$31.8M
-2
Closed
QTRX icon
447
Quanterix
QTRX
$139M
-415
Closed -$5K
RANI icon
448
Rani Therapeutics
RANI
$90.2M
-229
Closed -$2K
RDHL
449
Redhill Biopharma
RDHL
$3.59M
-1
Closed
RIGL icon
450
Rigel Pharmaceuticals
RIGL
$782M
-162
Closed -$2K

Similar funds

China Universal Asset Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
  • China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
  • China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
  • China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
  • China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
  • China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.